S. Agrawal, A. Singh, Praveen Maheshwari, Bhushan Madke, Shubham Chopra
{"title":"吉非替尼引起痤疮样皮疹的局部维甲酸","authors":"S. Agrawal, A. Singh, Praveen Maheshwari, Bhushan Madke, Shubham Chopra","doi":"10.4103/jdmimsu.jdmimsu_462_22","DOIUrl":null,"url":null,"abstract":"Gefitinib is widely used chemotherapy drug for the treatment of malignant cancer. Dermatological manifestations with its intake have been reported in the seborrheic areas but occasionally described as widespread lesions. We are reporting a case who was on gefitinib having acneiform eruptions over the face which responded well to topical retinoids without any alteration in the regimen.","PeriodicalId":15592,"journal":{"name":"Journal of Datta Meghe Institute of Medical Sciences University","volume":"18 1","pages":"87 - 89"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Topical tretinoin in gefitinib-induced acneiform eruptions\",\"authors\":\"S. Agrawal, A. Singh, Praveen Maheshwari, Bhushan Madke, Shubham Chopra\",\"doi\":\"10.4103/jdmimsu.jdmimsu_462_22\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Gefitinib is widely used chemotherapy drug for the treatment of malignant cancer. Dermatological manifestations with its intake have been reported in the seborrheic areas but occasionally described as widespread lesions. We are reporting a case who was on gefitinib having acneiform eruptions over the face which responded well to topical retinoids without any alteration in the regimen.\",\"PeriodicalId\":15592,\"journal\":{\"name\":\"Journal of Datta Meghe Institute of Medical Sciences University\",\"volume\":\"18 1\",\"pages\":\"87 - 89\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Datta Meghe Institute of Medical Sciences University\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/jdmimsu.jdmimsu_462_22\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Datta Meghe Institute of Medical Sciences University","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jdmimsu.jdmimsu_462_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Topical tretinoin in gefitinib-induced acneiform eruptions
Gefitinib is widely used chemotherapy drug for the treatment of malignant cancer. Dermatological manifestations with its intake have been reported in the seborrheic areas but occasionally described as widespread lesions. We are reporting a case who was on gefitinib having acneiform eruptions over the face which responded well to topical retinoids without any alteration in the regimen.